Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma
Clinical trial NCT06788600 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06788600
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-01
- Primary completion
- 2026-10-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.